Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In Phase 1 and Phase 2 human studies (20222023) subjects showed weight reductions of up to 24 % of baseline over 48 weeks
Medication and Provider Background: The client was prescribed Wegovy, a GLP-1 medication, by her primary care physician (PCP) to address PCOS (Polycystic Ovary Syndrome) and prediabetes
Ideal for everyday use, it works to restore luminosity and hydration while helping to improve skin clarity over time
When to contact your GP : Discuss GLP-1 treatment if you have type 2 diabetes with suboptimal control despite lifestyle changes and other medications, or if you're struggling with obesity-related health complications despite sustained efforts at dietary modification and increased physical activity
In clinical trials it is evaluated for obesity, type 2 diabetes and steatotic liver disease
[PMID: 16455690] PubMed record related to this compound for laboratory literature review
